IP Library Granted Patent US 9,743,647
Granted Patent B2
US 9,743,647 · App. 14/791,978 · Granted Aug 29, 2017

Humanized IL-4 and IL-4Ra animals

Inventors: Li-Hsien Wang (Somers, NY); Yingzi Xue (Ardsley, NY); Andrew Murphy (Croton-on-Hudson, NY); Sean Stevens (San Diego, CA)
Assignee: REGENERON PHARMACEUTICALS, INC.
A01K67/0278C07K14/5406C07K14/7155A01K2207/15A01K2217/072A01K2217/20A01K2227/105A01K2267/01A01K2267/0368A01K2267/0393
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,743,647
App. No.
14/791,978
Granted
Aug 29, 2017
Kind
B2
Abstract

Non-human animals comprising a human or humanized IL-4 and/or IL-4Rα nucleic acid sequence are provided. Non-human animals that comprise a replacement of the endogenous IL-4 gene and/or IL-4Rα gene with a human IL-4 gene and/or IL-4Rα gene in whole or in part, and methods for making and using the non-human animals, are described. Non-human animals comprising a human or humanized IL-4 gene under control of non-human IL-4 regulatory elements is also provided, including non-human animals that have a replacement of non-human IL-4-encoding sequence with human IL-4-encoding sequence at an endogenous non-human IL-4 locus. Non-human animals comprising a human or humanized IL-4Rα gene under control of non-human IL-4Rα regulatory elements is also provided, including non-human animals that have a replacement of non-human IL-4Rα-encoding sequence with human or humanized IL-4Rα-encoding sequence at an endogenous non-human C IL-4Rα locus. Non-human animals comprising human or humanized IL-4 gene and/or IL-4Rα sequences, wherein the non-human animals are rodents, e.g., mice or rats, are provided.

Claims (8)

1. A rodent, comprising a replacement of a genomic DNA of a rodent IL-4Rα gene at an endogenous rodent IL-4Rα locus with a human genomic DNA of a human IL-4Rα gene to form a humanized IL-4Rα gene, wherein the genomic DNA of the rodent IL-4Rα gene comprises the ATG initiation codon of exon 1 through exon 5 of the rodent IL-4Rα gene, and the human genomic DNA of the human IL-4Rα gene comprises the ATG initiation codon of exon 1 through exon 5 of the human IL-4Rα gene; wherein the humanized IL-4Rα gene comprises the ATG initiation codon of exon 1 through exon 5 of the human IL-4Rα gene and exons 6-9 of the rodent IL-4Rα gene, and the human genomic DNA present in the humanized IL-4Rα gene begins with the ATG initiation codon in exon 1 of the human IL-4Rα gene; and wherein expression of the humanized IL-4Rα gene is under control of the rodent IL-4Rα promoter at the endogenous rodent IL-4Rα locus, wherein the rodent is a mouse or a rat.

2. The rodent of claim 1 , wherein the rodent is a mouse that is incapable of expressing a mouse IL-4Rα protein.

3. The rodent of claim 1 , wherein the rodent expresses a human or humanized IL-4 protein.

4. The rodent of claim 3 , wherein the rodent comprises a replacement of a genomic DNA of a rodent IL-4 gene at an endogenous rodent IL-4 locus with a genomic DNA of a human IL-4 gene to form a humanized IL-4 gene, wherein the genomic DNA of the rodent IL-4 gene comprises the ATG initiation codon of exon 1 through exon 4 of the rodent IL-4 gene, and the genomic DNA of the human IL-4 gene comprises the ATG initiation codon of exon 1 through exon 4 of the human IL-4 gene, and wherein expression of the humanized IL-4 gene is under control of the rodent IL-4 promoter at the endogenous rodent IL-4 locus.

5. The rodent of claim 1 , wherein the rodent is a mouse.

6. A method for making a humanized rodent, comprising replacing a genomic DNA of a rodent IL-4Rα gene at an endogenous rodent IL-4Rα locus with a human genomic DNA of a human IL-4Rα gene to form a humanized IL-4Rα gene, wherein the genomic DNA of the rodent IL-4Rα gene comprises the ATG initiation codon of exon 1 through exon 5 of the rodent IL-4Rα gene, and the human genomic DNA of the human IL-4Rα gene comprises the ATG initiation codon of exon 1 through exon 5 of the human IL-4Rα gene; wherein the humanized IL-4Rα gene comprises the ATG initiation codon of exon 1 through exon 5 of the human IL-4Rα gene followed by exons 6-9 of the rodent IL-4Rα gene, and the human genomic DNA present in the humanized IL-4Rα gene begins with the ATG initiation codon of exon 1 of the human IL-4Rα gene; and wherein the humanized IL-4Rα gene is operably linked to the rodent IL-4Rα promoter at the endogenous rodent IL-4Rα locus, wherein the rodent is a mouse or a rat.

7. The method of claim 6 , wherein the rodent is a mouse.

8. The rodent of claim 3 , wherein the rodent is a mouse that does not express a mouse IL-4 protein.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2015
From: WANG, LI-HSIEN; XUE, YINGZI; MURPHY, ANDREW J.; STEVENS, SEAN
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 036198/0485 →
Continuity (3)
Continuation 14706319 · May 7, 2015
Provisional Application 61989757 · May 7, 2014
Related Publication 20150320022A1 · Nov 12, 2015